|
Volumn 43, Issue 21, 2013, Pages 10-
|
FDA slaps regs on fecal transplants. Increased steps for C. diff treatment draw mixed reactions from providers.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOLOGICAL PRODUCT;
CLOSTRIDIUM DIFFICILE;
CLOSTRIDIUM INFECTION;
DRUG APPROVAL;
FECES;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
MICROBIOLOGY;
NOTE;
STANDARD;
UNITED STATES;
BIOLOGICAL AGENTS;
CLOSTRIDIUM DIFFICILE;
CLOSTRIDIUM INFECTIONS;
FECES;
HUMANS;
INVESTIGATIONAL NEW DRUG APPLICATION;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 84884307071
PISSN: 01607480
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (3)
|
References (0)
|